The Cutting Edge Technology Core Laboratory is based on the realization that technological developments an no longer be predicted with reliability for more than two or three years into the future. We have therefore proposed development of a novel resource that, under guidance of the Laboratory Director, Dr. Michael Lerner, the Executive Committee, the External Review Committee, and for budgetary purposes, the NIAMS, will enable investigators to seize new opportunities over the entire granting period. It is organized around 5 specific aims: (1) Identify emerging technologies that can be applied to skin- and skin disease- related research; (2) Select/target those technologies of particular utility for SDRC Investigators; (3) Participate in developing targeted technologies for skin research, in partnership with inventors on the UT Southwestern campus; (4) Adapt target technologies to the needs of SDRC Investigators; and (5) Expedite access of SDRC Investigators to developed/adapted technologies. In the first year, the Core will sponsor development, validation and services of a novel ultraviolet radiation device that controls both spectrum and timing (General Spectrum Generator System). In the second year Center investigators will be provided access to a system that facilitates identification of G-protein coupled receptors and ligands using GPCR Screening (Transmembrane Receptor Signaling). A leading candidate for the third year is use of X-ray crystallography for skin biology/disease research. With each subsequent year of funding, a new """"""""cutting-edge"""""""" technology will be selected for development and/or adaptation to skin research, based primarily on potential used by SDRC investigators. This novel Core Laboratory will enable SDRC investigators to develop and/or pioneer the use of modern technology through the 5- year granting period.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
2P30AR041940-10
Application #
6473060
Study Section
Special Emphasis Panel (ZAR1)
Project Start
1997-06-01
Project End
2006-05-31
Budget Start
Budget End
Support Year
10
Fiscal Year
2001
Total Cost
Indirect Cost
City
Dallas
State
TX
Country
United States
Zip Code
75390
Acharya, Asha; Baek, Seung Tae; Banfi, Serena et al. (2011) Efficient inducible Cre-mediated recombination in Tcf21 cell lineages in the heart and kidney. Genesis 49:870-7
Straud, Sarah; Zubovych, Iryna; De Brabander, Jef K et al. (2010) Inhibition of iron uptake is responsible for differential sensitivity to V-ATPase inhibitors in several cancer cell lines. PLoS One 5:e11629
Chapman, Shelby L; Sicot, F-X; Davis, Elaine C et al. (2010) Fibulin-2 and fibulin-5 cooperatively function to form the internal elastic lamina and protect from vascular injury. Arterioscler Thromb Vasc Biol 30:68-74
Yanagisawa, Hiromi; Davis, Elaine C (2010) Unraveling the mechanism of elastic fiber assembly: The roles of short fibulins. Int J Biochem Cell Biol 42:1084-93
Choi, Jiwon; Bergdahl, Andreas; Zheng, Qian et al. (2009) Analysis of dermal elastic fibers in the absence of fibulin-5 reveals potential roles for fibulin-5 in elastic fiber assembly. Matrix Biol 28:211-20
Jaeckle Santos, Lane J; Xing, Chao; Barnes, Robert B et al. (2008) Refined mapping of X-linked reticulate pigmentary disorder and sequencing of candidate genes. Hum Genet 123:469-76
Takayama, Yoshiharu; May, Petra; Anderson, Richard G W et al. (2005) Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor beta (PDGFR beta). J Biol Chem 280:18504-10
Wang, Huixia; He, Xuming; Band, Mark et al. (2005) A study of inter-lab and inter-platform agreement of DNA microarray data. BMC Genomics 6:71
Sinha, Suwan K; Zachariah, Sunny; Quinones, Herson I et al. (2002) Role of TRAF3 and -6 in the activation of the NF-kappa B and JNK pathways by X-linked ectodermal dysplasia receptor. J Biol Chem 277:44953-61
Kumar, A; Eby, M T; Sinha, S et al. (2001) The ectodermal dysplasia receptor activates the nuclear factor-kappaB, JNK, and cell death pathways and binds to ectodysplasin A. J Biol Chem 276:2668-77

Showing the most recent 10 out of 56 publications